Volume 19, Number 10—October 2013
Dispatch
New Clonal Strain of Candida auris, Delhi, India
Table 1
MIC, mg/L* |
Drug† |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
AMB |
FLU |
ITC |
VRC |
ISA |
POS |
FC |
CAS |
MFG |
AFG |
|
MIC50 | 0.25 | 32 | 0.125 | 0.5 | 0.125 | 0.125 | 0.125 | 0.25 | 0.06 | 0.25 |
MIC90 | 0.5 | 64 | 0.25 | 1 | 0.25 | 0.25 | 0.125 | 0.25 | 0.125 | 0.5 |
GM | 0.33 | 28.5 | 0.15 | 0.39 | 0.10 | 0.12 | 0.125 | 0.23 | 0.072 | 0.26 |
Range | 0.25–1 | 16–64 | 0.125–0.25 | 0.125–1 | <0.015–0.25 | 0.06–0.25 | 0.125 | 0.125–0.25 | 0.06–0.125 | 0.125–0.5 |
*MIC50, 50% minimum inhibitory concentration; MIC90, 90% minimum inhibitory concentration; GM, geometric mean of MICs.
†AMB, amphotericin B; FLU, fluconazole; ITC, itraconazole; VRC, voriconazole; ISA, isavuconazole; POS, posaconazole; FC, flucytosine; CAS, caspofungin; MFG, micafungin; AFG, anidulafungin.
Page created: September 16, 2013
Page updated: September 16, 2013
Page reviewed: September 16, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.